Eisler Capital (Us) LLC Merck & Co., Inc. Put Options Transaction History

Eisler Capital (Us) LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $1.7 Million - $1.82 Million	-13,700 Reduced 27.73%	35,700 $4.42 Billion
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $1.87 Million - $2.18 Million	16,500 Added 50.15%	49,400 $6.52 Billion
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $1.79 Million - $1.95 Million	17,900 Added 119.33%	32,900 $3.59 Billion
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $350,030 - $388,722	-3,400 Reduced 18.48%	15,000 $1.54 Billion
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $8.03 Million - $8.75 Million	-73,900 Reduced 80.07%	18,400 $2.12 Billion
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $9.5 Million - $10.6 Million	92,300 New	92,300 $9.82 Billion

3,828

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $293B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Us) LLC with notifications on news.